ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,304Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1171

$1.21M Total Retail Price of All Prescriptions

Rank: 31 out of 1171

969 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 969 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 969 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 20,928 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 1,165 960 1 6
WARFARIN SODIUM 883 715 2 12
LISINOPRIL 864 732 3 3
ATENOLOL 834 696 4 15
LEVOTHYROXINE SODIUM 707 593 5 4
HYDROCODONE-ACETAMINOPHEN 699 503 S3 6 8
OMEPRAZOLE 687 501 7 5
SIMVASTATIN 653 565 8 1
AMLODIPINE BESYLATE 611 482 9 2
METOPROLOL TARTRATE 559 469 10 11
LOSARTAN POTASSIUM 487 426 11 14
TRAMADOL HCL 436 351 12 18
METFORMIN HCL 425 356 13 7
HYDROCHLOROTHIAZIDE 410 348 14 9
PRAVASTATIN SODIUM 357 273 15 13
GABAPENTIN 335 259 16 16
FENTANYL 329 254 S2 17 89
TRAZODONE HCL 325 214 18 37
SERTRALINE HCL 323 267 19 23
GLIPIZIDE 301 249 20 47
POTASSIUM CHLORIDE 300 229 21 19
RANITIDINE HCL 272 237 22 38
PAROXETINE HCL 258 197 23 62
DONEPEZIL HCL 248 230 24 24
ALLOPURINOL 243 226 25 31
ATORVASTATIN CALCIUM 238 185 26 10
PANTOPRAZOLE SODIUM 224 157 27 29
PREDNISONE 218 155 28 39
ZOLPIDEM TARTRATE 211 160 29 21
GLYBURIDE 211 176 R 29 97
CARVEDILOL 200 192 31 20
LANTUS 200 159 31 46
DIOVAN 200 193 31 32
TAMSULOSIN HCL 182 150 34 28
DIGOXIN 181 173 35 68
KETOCONAZOLE 180 122 36 217
CLONIDINE HCL 170 155 37 45
ETODOLAC 170 117 37 236
ADVAIR DISKUS 165 128 39 51
CIPROFLOXACIN HCL 162 143 40 61
CYMBALTA 161 98 41 64
DILTIAZEM 24HR CD 150 138 42 101
MIRTAZAPINE 146 122 43 50
PROMETHAZINE HCL 144 82 R 44 87
JANUVIA 141 119 45 66
CITALOPRAM HBR 140 114 46 22
CLOPIDOGREL 137 122 47 35
AMITRIPTYLINE HCL 136 118 R 48 74
NEXIUM 135 63 49 25
AMOXICILLIN 135 105 49 111
RISPERIDONE 132 131 51 77
PROAIR HFA 131 97 52 49
BUSPIRONE HCL 131 104 52 129
NYSTATIN 126 83 54 128
SPIRONOLACTONE 123 95 55 53
FLUTICASONE PROPIONATE 122 89 56 30
ALENDRONATE SODIUM 119 100 57 33
ISOSORBIDE MONONITRATE ER 116 105 58 44
QUETIAPINE FUMARATE 114 71 59 54
METOPROLOL SUCCINATE 111 103 60 17
CYCLOBENZAPRINE HCL 109 61 R 61 67
BENAZEPRIL HCL 108 63 62 83
LOVASTATIN 108 67 62 36
DILTIAZEM 24HR ER 107 96 64 112
MELOXICAM 106 75 65 56
CEPHALEXIN 103 92 66 104
SYNTHROID 100 97 67 48
AZITHROMYCIN 100 81 67 43
METOLAZONE 93 78 69 206
LISINOPRIL-HYDROCHLOROTHIAZIDE 91 85 70 26
IPRATROPIUM-ALBUTEROL 89 67 71 130
PLAVIX 88 78 72 55
CRESTOR 87 69 73 27
OXYCODONE-ACETAMINOPHEN 86 50 S2 74 59
TRIAMCINOLONE ACETONIDE 84 72 75 133
SPIRIVA 84 60 75 57
LEVETIRACETAM 83 50 77 84
FLUOXETINE HCL 81 67 78 76
DIOVAN HCT 80 64 79 65
NITROGLYCERIN PATCH 79 75 80 261
KLOR-CON M20 78 51 81 41
PHENYTOIN SODIUM EXTENDED 78 51 81 137
CELEBREX 76 62 83 100
METOCLOPRAMIDE HCL 73 50 84 141
LEVOFLOXACIN 73 60 84 105
CLINDAMYCIN HCL 72 55 86 354
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 54 86 109
MECLIZINE HCL 71 65 88 115
HYDRALAZINE HCL 70 60 89 60
ESCITALOPRAM OXALATE 66 65 90 69
VERAPAMIL ER 65 53 91 91
MONTELUKAST SODIUM 64 33 92 149
NAMENDA 63 62 93 42
AMLODIPINE BESYLATE-BENAZEPRIL 62 51 94 70
OXYCODONE HCL 62 22 S2 94 79
CARTIA XT 59 58 96 428
DILTIAZEM ER 59 39 96 221
SINGULAIR 58 36 98 78
ACTOS 57 40 99 123
BUMETANIDE 57 55 99 93
NITROSTAT 57 47 99 180
FINASTERIDE 55 55 102 88
LYRICA 55 29 102 127
SUCRALFATE 52 37 104 182
ZOSTAVAX 52 49 104 187
DIVALPROEX SODIUM 52 35 104 106
AVODART 51 43 107 194
GENERLAC 51 38 107 374
COMBIVENT 50 31 109 152
FLUCONAZOLE 50 40 109 195
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.